Form 4: Columbia Financial, Inc. Executive Klimowich Reports Stock Transactions
SEC Form 4 Filing
John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc., reports acquisition of common stock and holdings in derivative securities.
Summary
- John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. [CLBK], filed a Form 4 on January 28, 2025, reporting changes in beneficial ownership.
- On January 24, 2025, Klimowich acquired 41.4046 shares of common stock at a price of $15.42 per share through a stock-based deferral plan.
- Following the reported transaction, Klimowich directly owns 59,169 shares of common stock.
- Klimowich also indirectly owns shares through various plans including a Stock-Based Deferral Plan (6,709.9496 shares), a 401(k) (17,130 shares), an ESOP (6,451 shares), a SERP (6,602 shares), a SIM (4,214 shares), Stock Award II (15,159 shares), and Stock Award III (13,165 shares).
- Klimowich also holds derivative securities in the form of stock options with various exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock transactions. The acquisition of shares could be seen as slightly positive, but it's not a significant event.
Positives
- The acquisition of shares by a key executive could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock ownership is common across the financial industry.
- Comparing Klimowich's holdings and transactions to those of executives at peer institutions like OceanFirst Financial Corp. or Investors Bancorp could provide a benchmark for assessing his level of investment in Columbia Financial.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding executive compensation and ownership.
- The transactions may have a minor impact on the stock price depending on market perception.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date from which stock options with an exercise price of $15.60 became exercisable. |
| 05/01/2024 | Date from which stock options with an exercise price of $15.94 began to vest. |
| 01/24/2025 | Date of the reported stock transaction. |
| 03/06/2025 | Date from which stock options with an exercise price of $16.49 begin to vest. |
| 01/28/2025 | Date of the Form 4 filing. |
| 03/06/2034 | Expiration date of stock options with an exercise price of $16.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.